Trending...
- YieldOMega Launches $DOUB Airdrop Campaign Ahead of TimeCurve Launch
- AI Is Closing the Gap Between Offshore Virtual Assistants and Onshore Staff
- XRPPower Continues Strengthening Its Global AI-Powered Blockchain Ecosystem
O'Donnell Brings Wealth of Antitrust, Complex Commercial Litigation Expertise in Pharma Industry
PHILADELPHIA, Jan. 24, 2023 /PRNewswire/ -- Melissa Hatch O'Donnell, a talented health care attorney with significant experience in antitrust law, False Claims Act, and other complex commercial litigation, has rejoined Troutman Pepper as a partner in the firm's Health Sciences Litigation Practice Group. O'Donnell returns to the firm's Philadelphia office after spending nearly four years in-house with Cigna, where she provided litigation and regulatory counsel, and focused on pharmacy benefit managers' relationships with pharmaceutical manufacturers, health plans, and pharmacies.
"We are delighted to welcome Melissa back to the firm," said Sean Fahey, chair of the firm's Health Sciences Litigation Practice Group. "As we see demand for top-flight health care-focused litigators continue to grow, her addition deepens our bench strength for clients, particularly in the critical areas of antitrust law and complex commercial litigation."
More on The PennZone
O'Donnell brings extensive experience handling class action and large multidistrict litigations, as well as commercial, antitrust, unfair trade practice, and health care litigation. Drawing from in-house experience at a multinational, publicly traded health solutions company, O'Donnell advises clients in the health care and life sciences sectors in matters involving civil and criminal antitrust, competition, and other regulatory risks.
"I am thrilled to return to Troutman Pepper and private practice," O'Donnell said. "My time in-house has given me critical insight into what clients value, and I look forward to applying that experience to counsel clients through their toughest antitrust, competition, and regulatory matters."
After earning her B.A. from Penn State University, O'Donnell earned both her J.D. and her M.A. in Bioethics from the University of Pennsylvania. Prior to transitioning in-house, O'Donnell began her legal career with Troutman Pepper in 2010.
Troutman Pepper's leading life sciences and health care practice counsels clients at all stages of the health care continuum – from drug development to clinical care – from emerging biotech to global pharma. The firm takes an integrated, interdisciplinary approach to counsel clients with complex, evolving needs, providing critical support including intellectual property prosecution and litigation, corporate finance and governance, privacy and cybersecurity, litigation, regulatory, and enforcement.
More on The PennZone
About Troutman Pepper
Troutman Pepper is a national law firm with more than 1,200 attorneys strategically located in 23 U.S. cities. The firm's litigation, transactional, and regulatory practices advise a diverse client base, from start-ups to multinational enterprises. The firm provides sophisticated legal solutions to clients' most pressing business challenges, with depth across industry sectors, including energy, financial services, health sciences, insurance, and private equity, among others. Learn more at troutman.com.
SOURCE Troutman Pepper Hamilton Sanders LLP
PHILADELPHIA, Jan. 24, 2023 /PRNewswire/ -- Melissa Hatch O'Donnell, a talented health care attorney with significant experience in antitrust law, False Claims Act, and other complex commercial litigation, has rejoined Troutman Pepper as a partner in the firm's Health Sciences Litigation Practice Group. O'Donnell returns to the firm's Philadelphia office after spending nearly four years in-house with Cigna, where she provided litigation and regulatory counsel, and focused on pharmacy benefit managers' relationships with pharmaceutical manufacturers, health plans, and pharmacies.
"We are delighted to welcome Melissa back to the firm," said Sean Fahey, chair of the firm's Health Sciences Litigation Practice Group. "As we see demand for top-flight health care-focused litigators continue to grow, her addition deepens our bench strength for clients, particularly in the critical areas of antitrust law and complex commercial litigation."
More on The PennZone
- D.R. Crotzer Announces A New Science Fiction Book Series Exploring Life Energy, Dreams, and the Mystery of Existence
- Vinnie Rocco Opens AgentiX Minds To Help Business Owners & Execs Learn AI Agents
- Color Card Administrator Highlights Growing Enterprise Demand for Operational Infrastructure in Business Card Identity Governance
- American Properties Celebrates Grand Opening and Ribbon Cutting Ceremony at Heritage at South
- MoMojo Records signs Arlen Roth; "Blues Grass" slated for August 7, 2026 release
O'Donnell brings extensive experience handling class action and large multidistrict litigations, as well as commercial, antitrust, unfair trade practice, and health care litigation. Drawing from in-house experience at a multinational, publicly traded health solutions company, O'Donnell advises clients in the health care and life sciences sectors in matters involving civil and criminal antitrust, competition, and other regulatory risks.
"I am thrilled to return to Troutman Pepper and private practice," O'Donnell said. "My time in-house has given me critical insight into what clients value, and I look forward to applying that experience to counsel clients through their toughest antitrust, competition, and regulatory matters."
After earning her B.A. from Penn State University, O'Donnell earned both her J.D. and her M.A. in Bioethics from the University of Pennsylvania. Prior to transitioning in-house, O'Donnell began her legal career with Troutman Pepper in 2010.
Troutman Pepper's leading life sciences and health care practice counsels clients at all stages of the health care continuum – from drug development to clinical care – from emerging biotech to global pharma. The firm takes an integrated, interdisciplinary approach to counsel clients with complex, evolving needs, providing critical support including intellectual property prosecution and litigation, corporate finance and governance, privacy and cybersecurity, litigation, regulatory, and enforcement.
More on The PennZone
- Crosswalk Ministries USA Announces 2026 Child and Family Well-Being Conference in Stockbridge, Georgia
- Autism Podcast Helps Parents Understand Why Behavior Is Communication, Not Defiance
- Filmmaker Preston A. Dent to Premiere "Harrisburg-The Movie" at Whitaker Center for the Arts
- Pollock Begg Family Law Attorneys Earn 2026 Pennsylvania Super Lawyers Honors at Every Level
- Research reveals "The Borderless Pay Standard," a 48-point gap between multinational employers and workers on transparent pay expectations
About Troutman Pepper
Troutman Pepper is a national law firm with more than 1,200 attorneys strategically located in 23 U.S. cities. The firm's litigation, transactional, and regulatory practices advise a diverse client base, from start-ups to multinational enterprises. The firm provides sophisticated legal solutions to clients' most pressing business challenges, with depth across industry sectors, including energy, financial services, health sciences, insurance, and private equity, among others. Learn more at troutman.com.
SOURCE Troutman Pepper Hamilton Sanders LLP
Filed Under: Business
0 Comments
Latest on The PennZone
- Maryland Personal Injury Firm Earns National Recognition in 2026 ELA Awards
- Robert J. Bradshaw's AYE is a Gripping Dual Reality Thriller Exploring the Increasingly Blurred Line Between Humanity and Technology
- Bangxing Silicone Revolutionizes Silicone Baby Product Partnerships: Low MOQ Support + VIP Long-Term Win-Win Programs
- JFAB Consulting Elevates Brand with New Identity and Digital Experience
- SteelTree Announces Launch of Its Operational Decision Intelligence Service
- Advanced AI Capabilities Reflected by Upcoming Company Name and Stock Symbol Change for Evolving Pre-Owned Boat Dealer: Off The Hook YS: N Y S E: OTH
- AI-Driven Defense Expansion, Autonomous Systems and Israeli Aerospace Manufacturing Platform: VisionWave Holdings (N A S D A Q: VWAV)
- AI Predicts the Most Likely 2026 FIFA World Cup Winner
- The AI Production Shift: Why Game Development Is Entering Its Most Accelerated Phase
- World-First AI Humanoid Robot Debuts on Cherie Barber's Ground-breaking Australian Reno Show
- New Survey Reveals America's Most Feared Bridges for Cyclists — Golden Gate Tops the List
- Raymond Lavine, Extended Care Benefits Advisor and Author, to Appear on National Television Series Moving America Forward
- NaturismRE Launches Structured Nudism & Naturism Encyclopedia, Aiming to Reframe Public Understanding
- AiBT Advisory Launches AI Deployment Firm for the Mid-Market Companies Big AI Left Behind
- AI Is Closing the Gap Between Offshore Virtual Assistants and Onshore Staff
- CCHR Highlights Concerns Over Coercive and Failed $140 Billion Mental Health Practices at Psychiatric Convention
- Avery Headley Leads Major Stabilization and Modernization Initiative Across Bronx Affordable Housing Portfolio
- NewReputation's AI Sentiment Analysis Tool Reaches 2,500 Users as Businesses Demand Clearer Brand Intelligence
- CAPO Supply Announces Opening of Second Location in New Castle, Pennsylvania
- $224 Billion Growing Market in Life Settlements Presents Major Opportunity for New Policy Acquisition Business Plan: DLT Resolution Stock Symbol: DLTI
